summary answer: SOET is not inferior to traditional monitoring (non-SOET). what is known already: Monitoring the follicular phase is needed to adapt gonadotrophin dose, detect threatening hyperstimulation and plan HCG administration. Currently, patients pay visits to care providers, entailing transportation costs and productivity loss. It stresses patients, partners, care providers and the environment. Patients living at great distance from centres have more difficult access to treatment. The logistics and stress during the follicular phase of assisted reproduction treatment (ART) is often an impediment for treatment. study designs, size, duration: The study was a non-inferiority RCT between SOET and non-SOET performed between February 2012 and October 2013. Sample size calculations of number of metaphase II (MII) oocytes (the primary outcome): 81 patients were needed in each study arm for sufficient statistical power. Block randomization was used with allocation concealment through electronic files. The first sonogram was requested after 5 days of stimulation, after that mostly every 2 days and with a daily sonograms at the end.
Introduction
During the ovarian stimulation phase of assisted reproduction treatment (ART), the patient needs to be monitored for two main reasons: to increase or decrease the daily dose of gonadotrophins and to decide on the timely injection of HCG,. In addition, ovarian hyperstimulation syndrome (OHSS) can be prevented. Monitoring is achieved using serial vaginal sonograms, and counting the number and measuring the size of the follicles. The sonogram is performed by a gynaecologist, an IVF physician, a nurse or midwife and often is a very strenuous aspect of ART. Patients need to come, often from far away, to the centre for a relatively simple procedure. This entails an economic, logistic, emotional and potential environmental cost. For care providers sonograms represent a very routine procedure, reducing their time for more complex tasks.
Monitoring of ovarian stimulation is also based on serial measurements of serum estradiol (E 2 ), which is indeed essential in cases of OHSS but not for general use (Kwan et al., 2009) .
We have previously explored the possibility of monitoring patients at a distance, by teaching them to make their own vaginal sonograms at home (Gerris and De Sutter, 2010; Gerris et al., 2009) . We have conducted a prospective RCT comparing self-operated endovaginal telemonitoring (SOET) at home with traditional sonographic (non-SOET) follow-up.
Materials and Methods
This study was approved by the Ethical Committee of the University Hospital Ghent (EC/2011/669) and supported by an industrial research fund from Ghent University and a grant from the Flemish Government. Written consent was obtained from all patients.
Aim of the study
We hypothesized that self-monitoring (SOET) at home by the patient and traditional monitoring by medical staff (non-SOET) could result in similar laboratory and clinical outcomes, better patient-reported outcomes and a more favourable health-economic result for the S group. The primary outcome variable of the study, comparing the effect of ovarian stimulation, was the number of metaphase-II (MII) oocytes. Only ICSI attempts were therefore included, in which oocytes undergo denudation. Secondary outcome variables were patient-reported outcomes and health-economic variables. We wanted to compare two different strategies of monitoring, and therefore allowed all participating centres to use their own clinical and laboratory protocols.
Design of the study
A power calculation was performed prior to this RCT trial. Sample size calculations were based on the primary laboratory efficacy variable and calculated on the basis of historical data of numbers of metaphase-II oocytes at oocyte retrieval (OR) for women ,41 years of age with at least four oocytes at OR at our centre. Poor responders were excluded. Because the distribution of numbers of metaphase-II oocytes was skewed to the right, the analysis was performed on the log 2 -transformed numbers of metaphase-II oocytes. A sample size of 81 patients per group would allow for 80% power to demonstrate non-inferiority for the SOET group in a twosample T-test on the log 2 -transformed value of the primary outcome variable. Non-inferiority is defined as the SOET treatment having a number of metaphase-II oocytes at pick-up that is at least 80% of the number of metaphase-II oocytes at pick-up for standard monitoring (threshold limit for the difference of 0.32 on the log 2 -scale). Sample size calculation was performed under the further assumption that the true outcome of the SOET group is equal to the outcome of the standard nn-SOET stimulation.
Patient recruitment, study counselling, ovarian stimulation, sonographic follow-up, embryo transfer Eligible patients had to fulfil the following inclusion criteria: ,41 years of age, two ovaries, ICSI treatment. They needed a wireless internet connection at home and basic computer skills. Exclusion criteria were documented causes of severe distortion of the pelvic organs making sonography more difficult as well as poor responders (previously ,4 oocytes) and serum anti-Mullerian hormone value ,0.5 mIU/ml. Previous OHSS (at least 1 day of hospitalization in a previous ART attempt) and polycystic ovary syndrome (diagnosed using the Rotterdam criteria) were considered risk factors but not formal exclusion criteria.
Block randomization was conducted using electronic clinical research files, allotting each recruited patient at the time of enrolment to one of the groups.
Eligible patients were given a first general explanation of the concept of SOET as well as a letter of information explaining aims, methods and expectations. Patients could be enrolled at the time of the initial sonogram. Those who agreed to participate, were electronically randomized to either the SOET or the non-SOET arm of the study.
Enrolled patients were given a diary to fill in the data for calculating direct and indirect costs. The CONSORT-diagram is shown in Figure 1 .
Typically, patients were prepared for ICSI using an oral contraceptive. After withdrawal, a GnRH agonist was started using a short protocol (e.g. Decapeptyl, 0.1 mg/day for 7 days); after 3 days of the agonist, gonadotrophin stimulation was started, 150 IU being the usual starting dose. In case of previous OHSS, lower starting doses were used; in case of unexpected low response, a higher initial dose, with a maximum of 300 IU/day, was used.
SOET patients were shown how the server based communication software, developed at the faculty of engineering of Ghent University, Belgium, and the imaging software (NuWav, Laborie, Canada), worked. Patients were shown how to make video images, an how to upload and send them to the centre. They were given a laptop on which only the communication software and the imaging software were installed, a vaginal sonography probe with USB connection, a mouse, a power connection, condoms and gel. We used a 7.5 MHz endocavity probe for vaginal application (Laborie Medical, Inc., Toronto, Canada). They were instructed to send a first video recording soon after withdrawal bleeding in order to establish functional communication with the centre.
The video recordings were made by the patients by manually sweeping the probe. All measurements were performed by the care provider following up the stimulation. Patients scanned first their right ovary, then the uterus, then the left ovary. Before making actual recordings, the patient could explore how to make the best sweep using the screen of their laptop. After recording the sweep, lasting between 60 and 90 s for each ovary, and 30 s for the uterus, they could check the recorded images before sending them. If images were not considered appropriate, another recording could be made. Most patients learned quickly, finding their ovaries increasingly easily once they knew how to handle the probe within the vagina. With this pre-industrial hardware configuration, each recording was carried out, files were compressed, uploaded and sent separately. This could take up to 1 h (depending on the band width) but less than the time to travel to and from the centre, and was usually performed during leisure time.
Patients entering the SOET arm were monitored using home-made sonograms exclusively. They were not seen by a care provider between the day of the initial sonogram and the day of OR. If needed for clinical purposes (e.g. threatening OHSS), serum E 2 measurements could be performed in a laboratory near to the patient's home. Criteria for threatening OHSS were .15 follicles with a diameter of ≥15 mm or serum E 2 values .3000 pg/ml. Patients entering the non-SOET arm were monitored as usual: some in-house, even if they lived at a distance from the centre; others by a 'satellite' centre or physician.
Videos were downloaded and opened in the imaging software in order to perform 2D-measurements of the follicles. All measurements were ART patients provide useful vaginal sonograms from home performed by the principal investigators. Video images could be stopped, played forward or backward using two callipers in order to measure each follicle at its largest diameters. Using the report function of the website, the patient then obtained instruction concerning hormonal dose continuation or adjustment and planning of the subsequent sonogram. When follicles were considered mature, an instruction for HCG administration was given and the patient returned the system at the time of puncture. Each participating centre used its standard stimulation protocols and criteria for HCG administration. At any time, direct communication by e-mail or telephone was possible in both directions, creating a direct line between the centre (midwives, doctor) and the patient.
The midwives or nurse-practitioners taught the patients how to introduce and handle the probe, how to find the uterus and resting suppressed ovaries with hardly visible follicles at the start of the cycle, which was not always possible. At the patient's side of the study website, still images of follicles in different stages of development and a video demonstration were available at all times. The primary image quality criterion was to detect follicles that were identifiable and measurable in serial recordings. The patients took no responsibility whatsoever for measuring, interpreting or making decisions. The role of the midwives was to assist when the system was explained to patients, to communicate with the patient by mail or telephone if needed and to collect the diaries and fill out the patient reported outcomes (PRO) questionnaires during the post-study visit.
All centres had to adhere to the Belgian legislation concerning the number of embryos to transfer aimed at minimizing the percentage of multiple pregnancies (De Sutter et al., 2003; Gerris 2005; Ombelet et al., 2005; De Neubourg et al., 2013; Peeraer et al., 2013) .
Outcome variables
For laboratory outcome we recorded the total number of oocytes at retrieval, the number of mature metaphase-II oocytes at retrieval, the percentage of metaphase-II oocytes over the number of follicles punctured, the total number of top quality embryos on Day 3 and Day 5 (Van Royen et al., 1999; Van den Abbeel et al., 2013) and the number of embryos transferred or cryopreserved (Day 5).
For clinical outcome we recorded the number of follicles ≥15 mm diameter prior to puncture, the total number of positive HCGs, and the number of ongoing pregnancies (.12 weeks, at least one fetus with cardiac beats). Conceptions and ongoing pregnancies were counted cumulatively: each conception resulting from a study cycle was counted. This allows us to include all conceptions both from fresh and from frozen/thawed embryo replacements. The conception with the longest gestation was considered as the one to include in the results.
Patient-reported outcome was assessed at the time of the SOET follow-up visit.
Input data for the health-economic analysis were collected through patient diaries. Costs related to these input data, calculated for the duration of the study, were obtained using published and unpublished sources.
Statistics
Primary non-inferiority efficacy analysis is based on the most conservative per protocol (PP) analysis, which strictly includes patients that performed at least one sonogram as determined by the randomization. Protocol violators are excluded from this analysis. Non-inferiority is only concluded for the primary end-point. Additional analyses based on the intention-to-treat (ITT) and as-treated analysis also support the non-inferiority conclusion.
In order to demonstrate non-inferiority with respect to the primary outcome variable, we needed to show that the number of M-II oocytes at OR was at least 80% of the number after standard monitoring.
A two-sided 95% confidence interval (CI) for the difference in mean log 2 n metaphase II oocytes of NS versus SOET monitoring was calculated, to evaluate the non-inferiority hypothesis. Clinical outcome measures, like proportions of positive HCG results and ongoing pregnancies, and PRO comparing SOET and non-SOET are compared using Fisher's exact tests.
Results

Patient characteristics
One hundred and eighty-five patients were recruited between February 2012 and October 2013, of whom 62 (34%) did not participate for a variety of reasons listed in Table I . Of 123 patients enrolled, 62 entered the non-SOET arm and 61 the SOET arm. Two patients, both belonging to the SOET arm, dropped out: one because she learned she had no insurance coverage and one who stopped treatment for unknown reasons. Two patients attributed to the SOET arm switched to traditional monitoring because of technical fall-out of the probe. In the ITT principle, they were analysed in the SOET arm. Table II describes the characteristics of 121 analysed patients (59 SOET, 62 non-SOET). Both groups were comparable with respect to age of the patient, age of the partner, BMI, smoking behaviour and duration of subfertility.
Laboratory results
Laboratory data are summarized in Table III (primary variables) and  Table IV (secondary variables). The median of the number of M-II oocytes was eight in the SOET group versus seven in the non-SOET group (ITT analysis). After log 2 -transformation of the number of M-II oocytes, the mean is 3.01 (SD ¼ 1.06) for the SOET arm versus 2.78 (SD ¼ 1.37) for the non-SOET arm (ITT analysis). The 95% CI for the average difference in log 2 n M-II oocytes non-SOET versus SOET is 20.24 (20.68; 0.19) (P ¼ 0.27), indicating non-inferiority of SOET monitoring.
A post hoc power analysis based on the most conservative PP analysis shows that group sample sizes of 57 women in the SOET arm and 62 women in the non-SOET arm achieve 29% power to detect non-inferiority using a two-sided 95% CI for the difference in means, assuming a common SD of 1.24, a true difference in means of 0 and a noninferiority limit of 0.32 on the log 2 -scale, comparing non-SOET versus SOET. Although underpowered, this study still shows non-inferiority of SOET versus non-SOET monitoring of ovarian stimulation in ART.
Results calculated for the PP analysis, excluding attempts with OR but without embryo transfer (either no eggs or no transferable embryos) (SOET: n ¼ 52; non-SOET: n ¼ 57), indicate non-inferiority for SOET in this scenario as well (20.21 (20.57; 0.14) ).
Clinical results
All patients finished their treatment attempt, except for two drop-outs. Two patients from the S group had a technical fall-out of their probe and continued in the traditional monitoring, coming to the centre. In two patients, imaging remained uncertain and they were asked to come to the centre. One was a poor responder who had her daily dose increased and continued successfully with home follow-up. The other had follicles that were almost mature, and received HCG the day after the routine sonogram. This is the only patient where the SOET approach can be considered to have failed, because the patient did not succeed in identifying the follicles. In all the other patients, no extra visits were needed between the initial sonogram and the OR. Almost all patients experienced stress of uncertainty for some days, especially when follicles were still small (,12 mm). Once the follicles became clearly visible, patients succeeded in recording adequate video sequences.
In the SOET group there were 58/61 OR procedures (one cancellation) and 54/61 embryo transfers (four patients with either no or only bad quality embryos). In the non-SOET group there were 59/62 retrievals and 57/62 transfers. All results are calculated per started attempt.
In Mean difference in log 2 n metaphase II-ova (95% CI), comparing non- SOET versus SOET 20.08 (20.25; 0.10) Mean difference in log 2 n is indicated in bold.
ART patients provide useful vaginal sonograms from home
Patient-reported outcomes
All patients were seen at a post-treatment consultation and asked to assess six outcome measures: satisfaction of the patient and of the partner, feeling of empowerment, active participation of the partner, stress and discretion. In five out of these six variables SOET scored better than non-SOET attempts (P-value ,0.001), while for stress the P-value was 0.06, indicating a trend. Almost all women indicated they experienced two types of stress. For stress that was related to organizational and logistic aspects of monitoring stimulation, they felt SOET scored better. However, the application of a novel technique induced stress, which disappeared as follicles became more clearly visible on the screen as days went by.
Health-economic analysis
A health-economic analysis was performed, with the aim to establish whether the cost for society and for the patient is different between SOET and non-SOET. A total of 121 cycles were analysed (62 NS, 59 S). The two drop-out cycles were excluded. Two other patients, who started in the S arm but continued in the standard way, were analysed in the SOET group. We summarized the most important findings in Table V . An average of 3.0 sonograms was performed in non-SOET cycles by care providers versus 5.4 sonograms in SOET cycles (P , 0.001). All patients used their car as means of transportation. In the non-SOET group, an average of 530 km (min: 26 km; max 5520 km) was covered versus 146 km (min.: 0 km; max.: 900 km) in the SOET group (P , 0.001). With a cost of E0.3456E/km (Fedweb, 2013) , average transportation cost was calculated at E183 per non-SOET cycle (min E9, max E1908) versus E51 per SOET cycle.
Based on an average cost of E280 per day absence from work, the average cost related to productivity loss was E423 per non-SOET attempt (min E0, max E2169) versus E96 per SOET attempt (min E0, max E837) (P , 0.001) More time was spent by care providers, on average, on SOET than on non-SOET attempts. However, midwives found their time was better structured: they spent more time at the start of the stimulation but much less at each monitoring session.
When all costs were added the average total cost per SOET attempt is approximately half that of a non-SOET attempt: E455 (95% CI ¼ E382-E529; min E199; max E1499) versus E894 (95% CI E729- Data were analysed using official cost data during the study period (February 2012 -October 2013 . Data are Cost (SD).
E1058; min E121, max E4428). The largest difference between groups lies with the loss of productivity and the transportation costs, favouring the home sonography.
Discussion
The monitoring of ovarian stimulation for ART using home sonography performed by the patient and her partner, compares favourably with the traditional follow-up method in which the patient has to present herself for each sonogram to a care provider. Patients and their partners were more satisfied; they felt empowered and experienced a higher sense of discretion. Active participation of the partner was higher and, overall, the couple experienced less stress. Total costs were approximately halved when using SOET, creating the possibility of a shift of the cost of transportation or productivity loss experienced by the employer towards a reasonable service cost for the patient. Although the present study is a RCT and the results are statistically valid, the trial was finally underpowered. Technological improvements must still be made and tested with respect to both hard-and software. External validation in luminary sites is important. Not all patients are interested in using the system.
The low-end apparatus to be further developed for this application must not necessarily yield the same high-quality images as existing sonographic instruments; It should produce images that will allow the clinician to make the same clinical decisions as those made using the high-end devices.
Recent publications have reported attempts to automate follicular size measurements, based on 3D or volumetric measurements rather than on routinely used 2D measurements (Raine-Fenning et al., 2007 , 2008 Deutch et al., 2009; Salama et al., 2010; Ata and Tulandi, 2011; Vandekerckhove et al., 2013) . In the future, the application of post-processing technology will further facilitate the analysis of patient-generated video sequences.
